Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Schizophrenia01:17

Schizophrenia

Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those diagnosed.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diffusion tensor imaging along the perivascular space and disease progression in people with multiple sclerosis: a 5-year longitudinal MRI study.

Brain communications·2026
Same author

Lower vascular cerebral flow and cerebral perfusion may be associated with impairment of the glymphatic system in multiple sclerosis: A cross-sectional DTI-ALPS MRI study.

Journal of the neurological sciences·2025
Same author

Real-world effectiveness of horizontal switching between disease-modifying therapies in multiple sclerosis: a retrospective analysis of the MSBase Registry.

Therapeutic advances in neurological disorders·2025
Same author

Auditory test of processing speed: Further validation and test-retest reliability.

Multiple sclerosis and related disorders·2025
Same author

Neurophysiological indices of distinct cognitive operations during symbol digit modalities test performance in multiple sclerosis: a pilot study.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2025
Same author

Frailty Exacerbates Disability in Progressive Multiple Sclerosis.

Annals of clinical and translational neurology·2025

Related Experiment Video

Updated: May 30, 2026

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
05:44

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Gerstmann-Sträussler-Scheinker syndrome masquerading as multiple sclerosis.

Yuval Karmon1, Arielle Kurzweil, Eric Lindzen

  • 1Baird MS Center, Jacobs Neurological Institute SUNY Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY 14203, United States. yuvalk1@hotmail.com

Journal of the Neurological Sciences
|August 16, 2011
PubMed
Summary

Gerstmann-Sträussler-Scheinker syndrome (GSS), a rare inherited prion disease, can mimic other neurological disorders due to its varied presentation. This case highlights GSS

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Related Experiment Videos

Last Updated: May 30, 2026

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis
05:44

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Area of Science:

  • Neuroscience
  • Genetics
  • Neuropathology

Background:

  • Gerstmann-Sträussler-Scheinker syndrome (GSS) is a rare, inherited human prion disease characterized by neurodegeneration.
  • It typically follows an autosomal dominant inheritance pattern and exhibits significant genetic and phenotypic heterogeneity.
  • GSS is known for its prolonged clinical course, often mimicking other neurological conditions.

Observation:

  • A patient presented with a progressive ataxic syndrome.
  • Initial magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) findings suggested a demyelinating-inflammatory process, such as multiple sclerosis.
  • Subtle diagnostic clues eventually led to the identification of GSS.

Findings:

  • The case illustrates the diagnostic challenges posed by GSS, particularly when its symptoms overlap with other neurological disorders.
  • Advanced diagnostic techniques and careful clinical correlation were crucial in differentiating GSS from initial misdiagnoses.
  • This underscores the importance of considering rare prion diseases in the differential diagnosis of progressive neurological syndromes.

Implications:

  • Accurate and timely diagnosis of GSS is essential for patient management and genetic counseling.
  • Understanding the phenotypic variability of GSS can improve diagnostic accuracy in clinical practice.
  • Further research into GSS pathogenesis may reveal novel therapeutic targets for prion diseases.